Skip to main content

How the EVOQ platform works

Structure is engineered at the point of production. That's what makes this different.

The manufacturing breakthrough

EVOQ uses a patented high-energy laser ablation process to produce metamaterials continuously. No wet-chemistry reduction steps. No chemical waste streams. The process yields uniform spheres with a consistent size profile, engineered directly at production without post-processing. Shape, size, stability, and scalability are built in at formation. Primary applications in active development: medical device coatings and inhaled therapeutic systems. Energy, agriculture, and advanced polymers are under evaluation.

1. Shape

A pioneering and unique high-energy laser ablation technique produces metamaterial in reliably uniform and smooth spheres.

2. Size

The patented production method creates consistently sized metamaterial (10nm ±4) in a very narrow size distribution. Allowing for use across many applications and industries without costly secondary production processes.

3. Stability

This engineered metamaterial doesn’t have an oxidative layer, meaning no ion emission. The short bond lengths created at production also means they are long-lasting and stable without the use of capping agents.

4. Scalability

The EVOQ production process is cost-effective and scalable, making it a transformative leap in the creation of metamaterial. Scalability matters with up to 500x less cost than typical methods.

EVQ-218: the platform in practice

EVQ-218 is the EVOQ silver metamaterial. It's the most extensively evaluated implementation of the platform.

In laboratory studies, EVQ-218 demonstrated broad-spectrum antimicrobial activity across 64+ bacterial, fungal, and mycobacterial isolates. No resistance was detected after serial passage across all six ESKAPE pathogens under tested conditions.

Download the infographic
EVQ-218 killing bacteria without creating antimicrobial resistance

A material-agnostic platform

The platform is material-agnostic by design. Silver substantiates it. It doesn't define its limits.

Medical device coatings and inhaled therapeutics are in active development. Energy systems, industrial integration, and agriculture are under evaluation.

matematerial 2

Scalable production

The patented manufacturing process produces stable, non-emissive metamaterials with uniform spherical structures under characterized analytical conditions.

The laser-based process enables consistent, scalable production. No batch variability. No wet-chemistry bottlenecks. Orders of magnitude less costly than conventional nanoscale synthesis.

matematerial 2

Interested in testing EVOQ metamaterials?

Connect with the team to discuss your application.